not losing weight on tirzepatide 10mg How Much Will I Lose Tirzepatide? Clinical Data & Expectations Not Losing Weight on Tirzepatide?

This triple-action mechanism distinguishes retatrutide from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 receptor agonist), though no head-to-head clinical outcome trials comparing these agents have yet been published

Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity: Preliminary evaluation does not suggest a causal link [Drug Safety Communication]

Think of it as a little helper for your appetite

Which Pharmacies Fill GobyMeds Prescriptions

Breast Cancer: A 3047% Risk Reduction Among the most clinically significant findings was a real-world cohort study presented at ASCO 2026, which reported that women with Type 2 diabetes or obesity using GLP-1 receptor agonists experienced a 30 to 47% reduction in breast cancer risk compared to non-users